News Update: Neurocrine Biosciences Said Potential Treatment for Depressive Disorder Was Ineffective

News Update: Neurocrine Biosciences Said Potential Treatment For Depressive Disorder Was Ineffective — Neurocrine Biosciences (NASDAQ:NBIX) said that a potential treatment for a major depressive disorder was ineffective in midstage study. The study on GSK56167…

Find More Drug Treatment News 2010 Information…